動物医療の世界市場2020-2027:動物種類別(生産動物、コンパニオンアニマル)、製品別、荷渡方法別、エンドユーザー別、地域別

Table Of Contents

Chapter 1 Research Methodology & Scope
1.1 Market Segmentation & Scope
1.1.1 ESTIMATES AND FORECAST TIMELINE
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database:
1.3.2 GVR’S Internal database
1.3.3 Secondary Sources
1.3.4 Primary Research:
1.3.5 Details of Primary Research
1.3.6 Data for Primary Interviews In North America
1.3.7 Data for Primary Interviews In Europe
1.3.8 Data for Primary Interviews In Asia Pacific
1.3.9 Data for Primary Interviews In Latin America
1.3.10 Data for Primary Interviews In MEA
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (MODEL 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 Report Objectives
Chapter 2 Executive Summary
2.1 Market Outlook
2.1.1 Veterinary medicine market outlook, 2016 – 2027 (USD MILLION)
2.2 Segment Outlook
2.3 Competitive Outlook
2.4 Veterinary Medicine Market Summary, 2019
Chapter 3 Veterinary Medicine Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 PARENT MARKET ANALYSIS
3.1.1.1 Animal health Market Outlook, 2016 – 2027 (USD Million)
3.2 Penetration & Growth Prospect Mapping
3.3 Veterinary Medicine Market Dynamics
3.3.1 MARKET DRIVER ANALYSIS
3.3.1.1 Rise in livestock population and increasing pet ownership rates
3.3.1.2 Increase in number of Zoonotic & Chronic diseases
3.3.1.3 Rising R&D and procedural advancements
3.3.1.4 Increasing consumption of meats and mandatory vaccination
3.3.2 MARKET RESTRAINT ANALYSIS
3.3.2.1 Government intervention
3.3.2.2 Increasing influx of counterfeit drugs
3.3.2.3 Short product exclusivity period
3.4 Veterinary Medicine Market Analysis Tools: Porter’s
3.4.1 Supplier Power
3.4.2 Buyer Power
3.4.3 Threat Of Substitutes
3.4.4 Threat of new entrants
3.4.5 Competitive rivalry
3.5 PESTEL Analysis
3.5.1 Political & legal landscape
3.5.2 Economic & social landscape
3.5.3 Technology landscape
3.5.4 Social landscape
Chapter 4 Veterinary Medicine Market: Competitive Analysis
4.1 Market Participation Categorization
4.2 Public Companies
4.2.1 Company market position analysis
4.2.2 Competitive dashboard analysis
4.2.3 Major deals & acquisitions
4.2.4 Estimated company market share analysis, 2019
4.3 Private Companies
4.3.1 List of private companies
4.4 Vendor Landscape
4.4.1 List of distributors
4.5 List of Parenteral Drugs
4.6 COVID-19 Impact
Chapter 5 Veterinary Medicine Market: Animal Type Estimates & Trend Analysis
5.1 Animal type Market Share Analysis, 2019 & 2027
5.2 Animal type Dashboard
5.3 Production Animal
5.3.1 Production animal market estimates and forecasts, 2016 – 2027 (USD MILLION)
5.3.2 Poultry
5.3.2.1 Poultry diseases prevalence analysis (2019)
5.3.2.2 Poultry market estimates and forecasts, 2016 – 2027 (USD Million)
5.3.3 Swine
5.3.3.1 Swine market estimates and forecasts, 2016 – 2027 (USD Million)
5.3.4 Cattle
5.3.4.1 Cattle market estimates and forecasts, 2016 – 2027 (USD Million)
5.3.5 Sheep & goats
5.3.5.1 Sheep & goats market estimates and forecasts, 2016 – 2027 (USD Million)
5.3.6 Fish
5.3.6.1 Fish market estimates and forecasts, 2016 – 2027 (USD Million)
5.4 Companion Animal
5.4.1 Companion animal market estimates and forecasts, 2016 – 2027 (USD MILLION)
5.4.2 Dogs
5.4.2.1 Dogs diseases prevalence analysis (2019)
5.4.2.2 Dogs core vaccination protocol:
5.4.2.3 Dogs non-core optional vaccination protocol
5.4.2.4 Vaccination Schedule for Dogs: Core and Non-core Vaccines
5.4.2.5 Dogs market estimates and forecasts, 2016 – 2027 (USD Million)
5.4.3 Cats
5.4.3.1 Cats diseases prevalence analysis (2019)
5.4.3.2 Cats core vaccination protocol:
5.4.3.3 Cats non-core optional vaccination protocol
5.4.3.4 Vaccination Schedule for Cats: Core and Non-core Vaccines
5.4.3.5 Cats market estimates and forecasts, 2016 – 2027 (USD Million)
5.4.4 Horses
5.4.4.1 Horses market estimates and forecasts, 2016 – 2027 (USD Million)
5.4.5 Others
5.4.5.1 Others market estimates and forecasts, 2016 – 2027 (USD Million)
Chapter 6 Veterinary Medicine Market: Product Estimates & Trend Analysis
6.1 Product Market Share Analysis, 2019 & 2027
6.2 Product Dashboard
6.3 Biologics
6.3.1 Biologics market estimates and forecasts, 2016 – 2027 (USD MILLION)
6.3.2 Vaccines
6.3.2.1 Vaccines market estimates and forecasts, 2016 – 2027 (USD Million)
6.3.2.2 Live attenuated vaccines
6.3.2.3 Live attenuated vaccines market estimates and forecasts, 2016 – 2027 (USD Million)
6.3.2.4 DNA vaccines
6.3.2.5 DNA vaccines market estimates and forecasts, 2016 – 2027 (USD Million)
6.3.2.6 Recombinant vaccines
6.3.2.7 Recombinant vaccines market estimates and forecasts, 2016 – 2027 (USD Million)
6.3.2.8 Inactivated vaccines
6.3.2.9 Inactivated vaccines market estimates and forecasts, 2016 – 2027 (USD Million)
6.3.2.10 Others
6.3.2.11 Others market estimates and forecasts, 2016 – 2027 (USD Million)
6.4 Pharmaceuticals
6.4.1 Pharmaceuticals market estimates and forecasts, 2016 – 2027 (USD MILLION)
6.4.2 Parasiticides
6.4.2.1 Parasiticides market estimates and forecasts, 2016 – 2027 (USD Million)
6.4.3 Anti-infectives
6.4.3.1 Anti-infectives market estimates and forecasts, 2016 – 2027 (USD Million)
6.4.4 Anti-inflammatory
6.4.4.1 Anti-inflammatory market estimates and forecasts, 2016 – 2027 (USD Million)
6.4.5 Analgesics
6.4.5.1 Analgesics market estimates and forecasts, 2016 – 2027 (USD Million)
6.4.6 Others
6.4.6.1 Others market estimates and forecasts, 2016 – 2027 (USD Million)
6.5 Medicinal feed additives
6.5.1 Medicinal feed additives market estimates and forecasts, 2016 – 2027 (USD MILLION)
Chapter 7 Veterinary Medicine Market: Mode of delivery Estimates & Trend Analysis
7.1 Mode of delivery Market Share Analysis, 2019 & 2027
7.2 Mode of delivery dashboard
7.3 Oral
7.3.1 Oral market estimates and forecasts, 2016 – 2027 (USD MILLION)
7.3.2 Powder
7.3.2.1 Powder market estimates and forecasts, 2016 – 2027 (USD Million)
7.3.3 Tablets
7.3.3.1 Tablets market estimates and forecasts, 2016 – 2027 (USD Million)
7.4 Parenteral
7.4.1 Parenteral market estimates and forecasts, 2016 – 2027 (USD MILLION)
7.5 Others
7.5.1 Others market estimates and forecasts, 2016 – 2027 (USD MILLION)
7.5.2 Suspension
7.5.2.1 Suspension market estimates and forecasts, 2016 – 2027 (USD Million)
7.5.3 Topical
7.5.3.1 Topical market estimates and forecasts, 2016 – 2027 (USD Million)
7.5.4 Carrier
7.5.4.1 Carrier market estimates and forecasts, 2016 – 2027 (USD Million)
Chapter 8 Veterinary Medicine Market: End-use Estimates & Trend Analysis
8.1 End-use Market Share Analysis, 2019 & 2027
8.2 End-use Dashboard
8.3 Reference laboratories
8.3.1 Reference laboratories market estimates and forecasts, 2016 – 2027 (USD Million)
8.4 Veterinary Hospitals and Clinics
8.4.1 Veterinary hospitals and clinics market estimates and forecasts, 2016 – 2027 (USD Million)
8.5 Point-Of-Care/In-House Testing
8.5.1 Point-of-care/in-house testing market estimates and forecasts, 2016 – 2027 (USD Million)
8.6 Others
8.6.1 Others market estimates and forecasts, 2016 – 2027 (USD MILLION)
Chapter 9 Veterinary Medicine Market: Regional Estimates & Trend Analysis, By, Animal Type, Product, Mode Of Delivery And End-Use
9.1 Regional Market Snapshot
9.2 Market Share Analysis by Country, 2019
9.2.1 North America
9.2.2 Europe
9.2.3 Asia Pacific
9.2.4 Latin America
9.2.5 MEA
9.3 North America
9.3.1 North America Veterinary medicine market estimates and forecasts, 2016 – 2027 (USD MILLION)
9.3.2 U.S.
9.3.2.1 U.S. veterinary medicine market estimates and forecasts, 2016 – 2027(USD Million)
9.3.3 Canada
9.3.3.1 Canada veterinary medicine market estimates and forecasts, 2016 – 2027(USD Million)
9.4 Europe
9.4.1 Europe veterinary medicine market estimates and forecasts, 2016 – 2027 (USD Million)
9.4.2 U.K.
9.4.2.1 U.K. veterinary medicine market estimates and forecasts, 2016 – 2027(USD Million)
9.4.3 Germany
9.4.3.1 Germany veterinary medicine market estimates and forecasts, 2016 – 2027 (USD Million)
9.4.4 France
9.4.4.1 France veterinary medicine market estimates and forecasts, 2016 – 2027 (USD Million)
9.4.5 Italy
9.4.5.1 Italy veterinary medicine market estimates and forecasts, 2016 – 2027 (USD Million)
9.4.6 Spain
9.4.6.1 Spain veterinary medicine market estimates and forecasts, 2016 – 2027 (USD Million)
9.4.7 Russia
9.4.7.1 Russia veterinary medicine market estimates and forecasts, 2016 – 2027 (USD Million)
9.5 Asia Pacific
9.5.1 Asia Pacific veterinary medicine market estimates and forecasts, 2016 – 2027 (USD MILLION)
9.5.2 Japan
9.5.2.1 Japan veterinary medicine market estimates and forecasts, 2016 – 2027 (USD Million)
9.5.3 China
9.5.3.1 China veterinary medicine market estimates and forecasts, 2016 – 2027 (USD Million)
9.5.4 India
9.5.4.1 India veterinary medicine market estimates and forecasts, 2016 – 2027 (USD Million)
9.6 Latin America
9.6.1 Latin America veterinary medicine market estimates and forecasts, 2016 – 2027 (USD MILLION)
9.6.2 Mexico
9.6.2.1 Mexico veterinary medicine market estimates and forecasts, 2016 – 2027 (USD Million)
9.6.3 Brazil
9.6.3.1 Brazil veterinary medicine market estimates and forecasts, 2016 – 2027 (USD Million)
9.6.4 Argentina
9.6.4.1 Argentina veterinary medicine market estimates and forecasts, 2016 – 2027 (USD Million)
9.7 MEA
9.7.1 MEA veterinary medicine market estimates and forecasts, 2016 – 2027 (USD MILLION)
9.7.2 South Africa
9.7.2.1 South Africa veterinary medicine market estimates and forecasts, 2016 – 2027 (USD Million)
9.7.3 Saudi Arabia
9.7.3.1 Saudi Arabia veterinary medicine market estimates and forecasts, 2016 – 2027 (USD Million)
Chapter 10 Company Profiles
10.1 Merck Animal Health
10.1.1 Company overview
10.1.2 Financial performance
10.1.3 R&D Expenditure
10.1.4 Product Benchmarking
10.1.5 Strategic Initiatives
10.2 Ceva Sante Animale
10.2.1 Company Overview
10.2.2 Financial Performance
10.2.3 Product Benchmarking
10.2.4 Strategic Initiatives
10.3 Vetoquinol S.A.
10.3.1 Company overview
10.3.2 Financial Performance
10.3.3 Product Benchmarking (Top Products As Per Estimated Revenue (2019))
10.3.4 Strategic initiatives
10.4 Zoetis
10.4.1 Company overview
10.4.2 Financial performance
10.4.3 Product benchmarking (Top Products As Per Estimated Revenue (2019))
10.4.4 Strategic initiatives
10.5 Boehringer Ingelheim GmbH
10.5.1 Company overview
10.5.2 Financial performance
10.5.3 Product benchmarking (Top Products As Per Estimated Revenue (2019))
10.5.4 Strategic initiatives
10.6 Elanco
10.6.1 Company overview
10.6.2 Financial performance
10.6.3 Product benchmarking (Top Ten Products As Per Estimated Revenue (2019))
10.6.4 Strategic initiatives
10.7 Nutreco N.V.
10.7.1 Company overview
10.7.2 Product benchmarking
10.7.3 Strategic initiatives
10.8 Virbac
10.8.1 Company overview
10.8.2 Financial performance
10.8.3 Product benchmarking (Top Products As Per Estimated Revenue (2019))
10.8.4 Strategic initiatives
10.9 Kindred Biosciences, Inc.
10.9.1 Company overview
10.9.2 Financial performance
10.9.3 R&D Expenditure
10.9.4 Product benchmarking
10.9.5 Strategic initiatives
10.10 Biogenesis Bago
10.10.1 Company overview
10.10.2 Financial performance
10.10.3 Product benchmarking
10.11 Indian Immunologicals Ltd.
10.11.1 Company overview
10.11.2 Financial performance
10.11.3 Product benchmarking
10.11.4 Strategic initiatives
10.12 Neogen Corporation
10.12.1 Company overview
10.12.2 Financial performance
10.12.3 Product benchmarking
10.12.4 Strategic initiatives
10.13 Hester Biosciences
10.13.1 Company overview
10.13.2 Financial performance
10.13.3 R&D expenditure
10.13.4 Product benchmarking
10.14 Phibro Animal Health
10.14.1 Company overview
10.14.2 Financial performance
10.14.3 R&D Expenditure
10.14.4 Product benchmarking (Top Products As Per Estimated Revenue (2019))
10.14.5 Strategic initiatives

グローバル市場調査会社